Janus tyrosine kinase (JAK) signaling may be involved in the pathogenesis of polymyalgia rheumatica (PMR), and tofacitinib may be an effective treatment, according to a pilot study published ...

Are you waking up in the morning with stiff hips, back and neck? You might want to get yourself checked for Polymyalgia Rheumatica (PMR). PMR is a condition characterized by inflammation that ...

Among 14 patients in a phase II study treated with the oral Janus-associated kinase (JAK) inhibitor, mean disease activity ratings on a standard scale fell from 50.9 points at baseline to just 1.3 ...

Polymyalgia rheumatica (PMR) is a common inflammatory condition affecting elderly people and involving the girdles. [1] The mainstay of treatment is oral glucocorticoids (GC), with the recent BSR ...

Sparrow Pharmaceuticals Presents Data from Ongoing Phase 2 Trial of Clofutriben (SPI-62) and Prednisolone as a Treatment for Polymyalgia Rheumatica at EULAR 2024 ...

Global Healthy Living Foundation Receives Four-Year CDC Grant to Elevate Polymyalgia Rheumatica Awareness and Education September 20, 2023 12:36 PM Eastern Daylight Time ...

This study looks to identify the optimal starting dose of prednisone for polymyalgia rheumatica patients.